UK’s largest independent chemical manufacturer takes drug testing in-house with Intelligent Fingerprinting Drug Screening System
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq:INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that Robinson Brothers, one of the UK’s largest independent chemical manufacturers, is now using its revolutionary portable Intelligent Fingerprinting Drug Screening System to support its drug and alcohol testing policy.
Related news for (INBS)
- Intelligent Bio Solutions Secures Major UK Contract with Multinational Industrial Service Provider
- Today’s Top Performers: MoBot’s Market Review 10/23/25 08:00 AM
- 24/7 Market News Snapshot 23 October, 2025 – Intelligent Bio Solutions Inc. Common Stock (NASDAQ:INBS)
- Intelligent Bio Solutions Accelerates Global Growth with SmarTest® Patch Agreement, Reinforces U.S. Expansion Path as FDA Approval Remains a Strategic Priority
- 24/7 Market News Snapshot 16 July, 2025 – Intelligent Bio Solutions Inc. Common Stock (NASDAQ:INBS)